Has Olympia Pharmacy had FDA inspection findings? Form 483 and letter records
Has Olympia Pharmacy had FDA inspection problems?
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists OPS International, Inc., (dba Olympia Pharmacy), a 503B outsourcing facility in Orlando, FL, with 4 Form 483s issued from 2022 to Sep 3, 2026 and no warning letter in the years the page covers (2019 on). FDA’s registered outsourcing facility list (updated Nov 6, 2026) names Olympia Pharmaceuticals in Orlando, FL (last inspected Sep 3, 2026, Form 483 issued, action “Open”).
A Form 483 lists an investigator’s observations and is not a final FDA determination. These records cover all of the facility’s compounding, not only GLP-1 drugs.
OPS International, Inc., (dba Olympia Pharmacy), Orlando, FL (503B)
FDA’s compounding inspections and actions page lists 5 actions for this entry.
| Document | |||
|---|---|---|---|
| Sep 3, 2026 | Form 483 | 483 Issued 09/03/2026 | fda.gov |
| Aug 8, 2025 | Amended Form 483 | Amended 483 Issued 08/08/2025 | fda.gov |
| May 29, 2024 | Form 483 | 483 Issued 05/29/2024 | FDA copy (archived) |
| Feb 22, 2023 | Regulatory meeting | Regulatory Meeting Held 02/22/2023 | Not linked by FDA |
| Mar 2, 2022 | Form 483 | 483 Issued 03/02/2022 | fda.gov |
A Form 483 lists investigator observations, not a final FDA determination.
On FDA’s registered 503B list
- Olympia Pharmaceuticals, Orlando, FL: first registered Mar 10, 2014, last inspection Sep 3, 2026, Form 483 Yes.
GLP-1 warning letters and recalls under this name
No FDA warning letter or openFDA recall report naming a GLP-1 drug in this index carries this name, as of Nov 15, 2026.
These records share a name. FDA lists each under its own legal name and address, and the records do not say how the entities are related.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
Records last pulled Nov 15, 2026. Every entry links to the original public record.